Literature DB >> 6754226

Use of pancreas-specific antigen in immunodiagnosis of pancreatic cancer.

R Loor, N J Nowak, M L Manzo, H O Douglass, T M Chu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6754226

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN： 0272-2712            Impact factor:   1.935


× No keyword cloud information.
  8 in total

1.  Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase.

Authors:  Nicholas O Roman; Betty K Samulitis; Lee Wisner; Terry H Landowski; Robert T Dorr
Journal:  Cancer Chemother Pharmacol       Date:  2010-03-26       Impact factor: 3.333

2.  Molecular mechanisms underlying Ca2+-mediated motility of human pancreatic duct cells.

Authors:  Hui Dong; Ki-Nam Shim; Jenny M J Li; Christine Estrema; Tiffany A Ornelas; Flang Nguyen; Shanglei Liu; Sonia L Ramamoorthy; Samuel Ho; John M Carethers; Jimmy Y C Chow
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

3.  Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines.

Authors:  B K Chang; R J Bergeron; C W Porter; J R Vinson; Y Liang; P R Libby
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Antitumor effects of N-alkylated polyamine analogues in human pancreatic adenocarcinoma models.

Authors:  B K Chang; R J Bergeron; C W Porter; Y Liang
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines.

Authors:  Robert T Dorr; Mary Ann Raymond; Terry H Landowski; Nicholas O Roman; Shoji Fukushima
Journal:  Int J Gastrointest Cancer       Date:  2005

6.  A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.

Authors:  Jianliang Zhang; Di-Hua He; Maria Zajac-Kaye; Steven N Hochwald
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  TGF-beta downregulates PTEN via activation of NF-kappaB in pancreatic cancer cells.

Authors:  Jimmy Y C Chow; Makiko Ban; Helen L Wu; Flang Nguyen; Mei Huang; Heekyung Chung; Hui Dong; John M Carethers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-25       Impact factor: 4.052

8.  The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential.

Authors:  SangWun Kim; Reyhaneh Lahmy; Chelsea Riha; Challeng Yang; Brad L Jakubison; Jaco van Niekerk; Claudio Staub; Yifan Wu; Keith Gates; Duc Si Dong; Stephen F Konieczny; Pamela Itkin-Ansari
Journal:  Pancreas       Date:  2015-07       Impact factor: 3.327
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.